Kimia Farma Persero Tbk

Kimia Farma Persero Tbk

KAEF · JK · Healthcare / Medical Distribution

394.00IDR-10.00 (-2.48%)

Price History

Full chart

Market Stats

Previous Close404.00
Open402.00
Day Range392.00 – 420.00
52-Week Range380.00 – 785.00
Volume702.50K
Market Cap2.29T
P/E (TTM)0.00
Forward P/E0.00
EPS-41.24
Dividend Yield0.00%
Beta1.03
50-Day Avg442.46
200-Day Avg482.07

About

PT Kimia Farma Tbk, together with its subsidiaries, manufactures and sells a range of medicines in Indonesia and internationally. It operates through Manufacture, Distribution, Retail, and Others segments. The company offers drugs in the form of tablets, effervescent tablets, hard and soft capsules, liquids, syrups, oral powders, non-beta-lactam external liquids, beta-lactam tablets and dry syrups, injections, ointments, creams, suppositories, semisolid dosage forms, and health supplements; traditional medicines; generic drugs, such as paracetamol, amoxicillin, and omeprazole; ethical products; over-the-counter products and herbs; and narcotic drugs and psychotropics. It also provides health food; cosmetics; edible, castor, and essential oils; active pharmaceutical ingredients and high-function chemicals; quinine salt and its derivatives; antiseptic solutions; stem cells; and medical devices. In addition, the company engages in the provision of integrated health services, including pharmacies, health and beauty clinics, clinical and diagnostic laboratories, and optics; pharmacy retail management; and distribution of medicines to pharmacies, hospital pharmacies, medical centers, and drug stores, as well as cosmetics and medical devices. It exports its products to Asia, Europe, Australia, Africa, and America. The company was founded in 1817 and is headquartered in Jakarta Pusat, Indonesia. PT Kimia Farma Tbk operates as a subsidiary of PT. Bio Farma.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEODjagad Prakasa Dwialam
  • Employees9.36K
  • HeadquartersJalan Veteran No.9, Jakarta Pusat, Indonesia, 10110, Indonesia
  • Websitehttps://www.kimiafarma.co.id

Leadership

  • Djagad Prakasa DwialamPresident Director
  • Willy MeridianFinance & Risk Management Director and Director
  • Ms. . RosriniCompliance & Risk Management Unit Manager · b. 1971
  • Ms. Eva FairusGeneral Manager of Marketing & Sales · b. 1967
  • Mr. Disril Revolin PutraDirector of Human Resources & Director · b. 1965
  • Budi Her Utomo CIA, CPIA, M.M.Head of Internal Audit
  • Mr. Hadi KardokoProduction & Supply Chain and Director & Director · b. 1976
  • Mr. Hanadi SetiartoCommercial Director & Director
  • Mr. Ganti Winarno PutroGeneral Manager of Corporate Secretary · b. 1979

Financials

Income Statement

Currency: IDR2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.54T1.82T1.93T1.82T2.19T2.37T2.70T2.85T3.18T3.48T3.73T4.35T4.52T4.86T5.81T6.13T7.45T9.40T10.01T12.86T9.23T9.97T9.94T9.22T
Growth (%)-+18.05%+6.03%-5.69%+20.55%+8.03%+14.33%+5.52%+11.55%+9.34%+7.27%+16.44%+3.98%+7.51%+19.57%+5.44%+21.65%+26.11%+6.44%+28.50%-28.19%+7.93%-0.26%-7.20%
Cost of Revenue1.09T1.26T1.25T1.21T1.57T1.69T1.98T2.07T2.28T2.44T2.56T3.06T3.14T3.32T3.95T3.93T4.67T5.90T6.35T8.46T6.01T7.18T6.99T6.54T
Gross Profit------722.25B788.25B904.52B1.04T1.18T1.29T1.39T1.54T1.86T2.20T2.78T3.50T3.66T4.40T3.52T2.78T2.95T2.68T
Gross Margin------26.70%27.62%28.41%29.82%31.47%29.72%30.65%31.62%32.07%35.93%37.30%37.27%36.55%34.19%38.07%27.90%29.65%29.10%
Operating Expense------615.21B676.32B758.32B816.01B890.01B998.39B1.04T1.16T1.42T1.67T2.02T3.00T3.00T3.41T3.02T4.35T3.76T2.93T
Operating Income60.87B88.66B124.71B84.72B60.63B77.50B107.04B111.93B146.20B222.00B285.16B293.77B342.48B374.28B442.82B535.66B765.02B501.66B653.02B985.64B497.05B-1.57T-810.72B-248.17B
Operating Margin3.96%4.88%6.48%4.66%2.77%3.28%3.96%3.92%4.59%6.38%7.64%6.76%7.58%7.70%7.62%8.74%10.26%5.34%6.53%7.67%5.38%-15.76%-8.16%-2.69%
EBITDA------136.47B145.45B216.97B288.65B304.82B293.89B379.72B418.84B492.86B608.37B1.16T695.94B914.09B1.39T1.02T-1.22T-265.60B239.93B
EBITDA Margin------5.05%5.10%6.81%8.29%8.16%6.76%8.40%8.62%8.48%9.93%15.58%7.40%9.14%10.82%11.04%-12.28%-2.67%2.60%
Net Income35.41B42.93B82.52B52.83B43.99B52.19B55.39B62.51B138.72B171.77B205.13B214.55B234.63B248.85B267.41B326.79B415.90B-12.72B17.64B302.27B-190.47B-1.49T-842.27B-334.96B
Net Income Margin2.30%2.36%4.28%2.91%2.01%2.21%2.05%2.19%4.36%4.93%5.49%4.93%5.19%5.12%4.60%5.33%5.58%-0.14%0.18%2.35%-2.06%-14.91%-8.47%-3.63%
R&D----7.92B7.01B7.45B8.92B8.83B11.50B14.79B17.25B15.27B19.13B24.45B37.43B18.07B15.32B15.53B41.35B46.37B108.10B31.62B41.13B
R&D as % of Total Revenue----0.36%0.30%0.28%0.31%0.28%0.33%0.40%0.40%0.34%0.39%0.42%0.61%0.24%0.16%0.16%0.32%0.50%1.08%0.32%0.45%
Interest Expense00000016.12B24.27B13.49B11.31B6.81B9.25B26.87B36.14B59.80B85.95B227.22B497.97B596.38B606.81B525.61B622.82B425.68B586.32B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.60%0.85%0.42%0.32%0.18%0.21%0.59%0.74%1.03%1.40%3.05%5.30%5.96%4.72%5.69%6.25%4.28%6.36%

Balance Sheet

Currency: IDR2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.04T1.37T1.17T1.18T1.26T1.39T1.45T1.56T1.66T1.79T2.08T2.47T2.97T3.24T4.61T6.10T9.46T18.35T17.56T17.76T20.35T17.59T14.97T14.18T
Total Liabilities361.25B612.31B358.85B333.38B390.57B478.71B497.91B567.31B543.26B541.74B634.81B847.58B1.16T1.37T2.34T3.52T6.10T10.94T10.46T10.53T11.01T11.19T11.54T11.67T
Total Equity677.30B754.46B814.58B844.22B870.65B908.03B947.76B995.32B1.11T1.25T1.43T1.61T1.79T1.84T2.22T2.51T3.20T7.24T6.99T7.14T7.14T5.89T2.29T2.66T
Cash119.90B231.49B154.76B132.87B210.38B224.51B221.96B163.82B265.45B199.39B316.50B394.15B573.36B460.99B647.68B989.64B1.96T1.36T1.25T748.48B2.19T832.67B437.59B653.58B
Total Debt------150.39B68.21B48.03B24.78B27.85B50.98B336.41B324.66B822.40B2.23T4.06T8.30T7.76T8.02T8.11T7.70T7.25T7.20T
Net Debt-------71.57B-95.61B-217.41B-174.61B-288.64B-343.17B-236.95B-136.33B174.71B1.03T2.08T6.94T6.51T7.28T5.96T6.87T6.81T6.55T

Cash Flow

Currency: IDR2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-314.63B-30.60B140.24B55.51B-28.69B122.01B141.37B83.91B230.61B253.78B286.31B202.84B213.43B32.64B195.75B-1.85T1.02T-223.92B403.34B-364.58B153.62B236.75B
Investing Cash Flow-------30.18B-75.51B-15.58B-56.75B-65.12B-172.81B-331.59B-228.50B-478.92B-810.24B-1.13T-2.12T-539.95B-648.45B-429.39B-722.50B34.40B-138.41B
Financing Cash Flow------56.31B-104.64B-24.17B-93.22B-48.38B-3.32B224.49B-59.83B467.56B1.15T1.84T3.28T-590.17B364.35B1.46T-272.03B-534.72B-159.55B
Capital Expenditure69.38B46.27B35.65B34.33B23.98B31.55B30.66B34.48B30.46B34.83B52.77B89.03B102.58B149.38B371.72B753.31B1.05T778.87B548.57B659.25B596.61B867.78B175.83B132.29B
Free Cash Flow-------59.35B87.53B110.92B49.08B177.85B164.75B183.73B53.46B-158.29B-720.67B-855.31B-2.63T470.40B-883.18B-465.33B-1.10T-22.22B104.46B
Dividends Paid59.16B10.62B17.17B23.19B15.61B15.61B17.81B13.85B-46.28B34.35B30.77B53.86B46.93B49.77B53.49B98.08B83.20B702.22M702.22M9.02B078.62M-
FCF to OCF------206.84%71.74%78.46%58.49%77.12%64.92%64.17%26.35%-74.17%-2208.10%-436.95%142.01%46.16%394.41%-115.37%302.58%-14.46%44.12%
Dividend Paid to FCF-------30.00%15.82%-94.30%19.32%18.68%29.31%87.78%-31.44%-7.42%-11.47%-3.16%0.15%-0.08%-1.94%0.00%-0.35%-

Earnings

Report DateJun 3, 2009Aug 28, 2009Dec 2, 2009Mar 3, 2010Feb 27, 2013May 29, 2013Aug 30, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 29, 2014Oct 28, 2014Mar 5, 2015Apr 29, 2015Jul 30, 2015Oct 29, 2015Mar 14, 2016Apr 28, 2016Jul 28, 2016Oct 28, 2016Mar 15, 2017May 31, 2017Jul 12, 2017Dec 1, 2017Mar 28, 2018May 30, 2018Aug 22, 2018Oct 31, 2018Mar 28, 2019May 6, 2019Sep 2, 2019Nov 1, 2019Mar 27, 2020Jun 3, 2020Aug 28, 2020Oct 30, 2020Mar 30, 2021Jun 2, 2021Aug 5, 2021Oct 29, 2021May 31, 2022Sep 30, 2022Oct 31, 2022Mar 29, 2023Apr 18, 2023Jul 28, 2023
EPS Estimate----------------------------------------------
EPS Actual2.260.342.226.4410.264.403.3014.1716.764.218.5013.1916.357.916.0415.5115.357.569.2914.4516.855.2611.8617.4524.276.7015.2718.6034.323.714.88-1.07-9.834.714.04-2.05-3.523.117.2643.991.04-37.97-37.971.960.07-3.98
Surprise----------------------------------------------
Timing-----------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursPre-marketAfter-hours-After-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours--------After-hoursAfter-hours-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap2.29T
Enterprise Value9.04T
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.24
Price / Book1.36
EPS-41.24
Book Value520.25
Revenue (TTM)9.56T
Gross Profit (TTM)2.99T
EBITDA326.76B
Profit Margin-2.40%
Operating Margin3.17%
Return on Equity-8.34%
Return on Assets-0.20%
Shares Outstanding5.57B
Shares Float566.57M
Beta1.03
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20221×
16.33May 23, 2022
20211×
1.27May 7, 2021
20191×
14.98May 16, 2019
20181×
17.66Apr 27, 2018
20171×
9.63May 2, 2017
20161×
8.96Apr 14, 2016
20151×
8.45Apr 16, 2015
20141×
9.66Apr 21, 2014
20131×
5.54May 2, 2013
20121×
6.18Jun 15, 2012
20112×
5.00Jul 8, 20113.38Feb 2, 2011
20091×
2.49Jun 26, 2009
20081×
2.82Jun 18, 2008
20071×
2.37Jun 19, 2007
20061×
2.85Jun 14, 2006
20051×
4.18Jun 3, 2005
20041×
3.09Jun 9, 2004
20031×
1.91Jun 9, 2003
20021×
10.72Jun 27, 2002